Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Genistin is a naturally occurring isoflavone glycoside found predominantly in soybeans and other legumes. Its aglycone form, genistein, has been the focus of most research, as genistin is rapidly converted to genistein in the human gut. The interest in genistin/genistein for osteoporosis management originates from epidemiological observations that populations consuming soy-rich diets have lower rates of osteoporotic fractures. Scientific studies suggest that genistein can exert estrogen-like effects by binding to estrogen receptors, particularly ER-β, which is highly expressed in bone tissue. These phytoestrogenic actions are hypothesized to help maintain bone density, especially in postmenopausal women who are at increased risk for osteoporosis due to declining estrogen levels. Preclinical animal studies have consistently shown that genistein and, by extension, genistin supplementation can reduce bone loss and improve bone strength. Some small-scale clinical trials in humans have reported modest increases in bone mineral density and favorable effects on bone turnover markers in postmenopausal women taking isoflavone supplements. However, the overall quality of clinical evidence is moderate at best, with some studies showing no significant benefit. Moreover, the optimal dose, duration, and long-term safety remain unclear. In summary, while there is a plausible scientific rationale and some clinical evidence supporting genistin's use for osteoporosis, the strength of the evidence is currently limited, justifying a moderate rating.

More about genistin
More about Osteoporosis

Other ingredients used for Osteoporosis

Other health conditions supported by genistin

Products containing genistin

Metagenics Testralin®